1,022
edits
Changes
Jump to navigation
Jump to search
Line 6:
Line 6: − + − +
→Rheumatoid Arthritis
=Rheumatoid Arthritis=
=Rheumatoid Arthritis=
*H&P: middle aged women, HLA-DR4 serotype; morning stiffness that lasts > 30 min and improves with activity
*H&P: middle aged women, HLA-DR4 serotype; morning stiffness that lasts > 30 min and improves with activity; Swan Neck deformity (PIP extension, DIP flexion), Boutonniere deformity (PIP flexion, DIP extension), ulnar deviation of MCP.
*Dx: 4 criteria for 6+ weeks. 3 or more joints (PIP, MCP, wrist, elbow, knee, ankle); symmetrical joint synovial hypertrophy with cartilage loss and osteoporosis on xray; elevated CRP, ESR (sensitive, not specific), rheumatoid factor (75% sensitive), or anti-CCP (most specific); inflammatory synovial fluid on joint aspiration; rheumatoid skin nodules (elbow most common).
*Dx: 4 criteria for 6+ weeks. 3 or more joints (PIP, MCP, wrist, elbow, knee, ankle); symmetrical joint synovial hypertrophy with cartilage loss and osteoporosis on xray; elevated CRP, ESR (sensitive, not specific), rheumatoid factor (75% sensitive), or anti-CCP (most specific); inflammatory synovial fluid on joint aspiration; rheumatoid skin nodules (elbow most common).
*Tx: NSAIDs and PT; Sulfasalazine, Hydroxychloroquine, or Glucocorticoids for milds disease; Methotrexate, anti-TNF biologics, or corticosteroids for moderate-severe disease; anti-TNF biologics AND corticosteroids for severe disease. Avoid methotrexate in patients with HIV, liver disease, ILD, renal disease, pregnancy, or bone marrow suppression; avoid anti-TNF in patients with TB.
*Tx: NSAIDs and PT; Sulfasalazine, Hydroxychloroquine, or Glucocorticoids for milds disease; Methotrexate, anti-TNF biologics, or corticosteroids for moderate-severe disease; anti-TNF biologics AND corticosteroids for severe disease. Avoid methotrexate in patients with HIV, liver disease, ILD, renal disease, pregnancy, or bone marrow suppression; avoid anti-TNF in patients with TB.
=Osteoarthritis=
=Osteoarthritis=